type here...
type here...
START FREE TRIAL

Healthcare

Technology & AIInformation TechnologyHealthcareM&AIndustrialsEnergy

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Healthcare Ishan Majumdar -
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05 billion in cash, marking one...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Healthcare Ishan Majumdar -
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its plan to acquire Cidara Therapeutics...
spot_imgspot_img

Cogent Biosciences’ Cancer Drug Exploded to 136% —Can the Rally Actually Last?

Healthcare Ishan Majumdar -
It’s not every day you see a biotech stock jump 136% before lunch. But that’s exactly what happened with...

Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen

Healthcare Ishan Majumdar -
Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private...

GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?

Healthcare Ishan Majumdar -
GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm...

Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit

Healthcare Ishan Majumdar -
Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...

Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism

Healthcare Ishan Majumdar -
Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...

Alcon’s Purchase Of STAAR Signals A New Chapter In Surgical Eye Care

Healthcare Ishan Majumdar -
Alcon’s recent agreement to acquire STAAR Surgical for $28 per share—representing a 59% premium to STAAR’s 90-day VWAP and...
Load more

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Healthcare Ishan Majumdar -
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Healthcare Ishan Majumdar -
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...

Cogent Biosciences’ Cancer Drug Exploded to 136% —Can the Rally Actually Last?

Healthcare Ishan Majumdar -
It’s not every day you see a biotech stock jump 136% before lunch. But that’s exactly what happened with...

Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen

Healthcare Ishan Majumdar -
Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private...

GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?

Healthcare Ishan Majumdar -
GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm...

Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit

Healthcare Ishan Majumdar -
Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...

Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism

Healthcare Ishan Majumdar -
Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...

Alcon’s Purchase Of STAAR Signals A New Chapter In Surgical Eye Care

Healthcare Ishan Majumdar -
Alcon’s recent agreement to acquire STAAR Surgical for $28 per share—representing a 59% premium to STAAR’s 90-day VWAP and...

Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!

Healthcare Ishan Majumdar -
Waters Corporation has officially entered a new phase of its growth journey with the $17.5 billion acquisition of Becton...

Bausch Health Strikes Bold With Durect Buy: A Strategic Bet On Liver Therapies?

Healthcare Ishan Majumdar -
Bausch Health Companies (NYSE:BHC) has made headlines with its definitive agreement to acquire liver-focused biotech Durect Corporation (NASDAQ:DRRX) for...

Axogen In Play? Here’s Why A Buyout Makes Sense At $18/Share

Healthcare Ishan Majumdar -
Axogen, Inc. (NASDAQ: AXGN) saw its stock jump nearly 4% after reports surfaced that the company is exploring a...

How Abbvie’s $1B Gilgamesh Bet Could Supercharge Its Next Growth Chapter

Healthcare Ishan Majumdar -
AbbVie’s reported discussions to acquire Gilgamesh Pharmaceuticals for approximately $1 billion mark the latest twist in the company’s aggressive...

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Google Gemini 3 AI: Big Bet or Bubble?

0
Alphabet just dropped its most advanced AI model to...

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

0
Johnson & Johnson just made another big move. The...

Nvidia Fall Risk? Peter Thiel Sells Nvidia

0
Just days after SoftBank revealed it had offloaded its...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

1
Merck isn’t waiting around for Keytruda’s patent clock to...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2025 Baptista Research. All rights reserved.